177 related articles for article (PubMed ID: 9209530)
1. Influence of brachytherapy applicators geometry on dose distribution in cervical cancer.
Senkus-Konefka E; Kobierska A; Jassem J; Serkies K; Badzio A
Strahlenther Onkol; 1997 Jun; 173(6):323-9. PubMed ID: 9209530
[TBL] [Abstract][Full Text] [Related]
2. Patient-related factors determining geometry of intracavitary applicators and pelvic dose distribution during cervical cancer brachytherapy.
Senkus-Konefka E; Kobierska A; Jassem J; Badzio A
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):531-6. PubMed ID: 9112449
[TBL] [Abstract][Full Text] [Related]
3. Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in Cervical Cancer Brachytherapy: Results From the EMBRACE I Study.
Serban M; Kirisits C; de Leeuw A; Pötter R; Jürgenliemk-Schulz I; Nesvacil N; Swamidas J; Hudej R; Lowe G; Hellebust TP; Menon G; Oinam A; Bownes P; Oosterveld B; De Brabandere M; Koedooder K; Langeland Marthinsen AB; Whitney D; Lindegaard J; Tanderup K;
Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):1052-1062. PubMed ID: 32007365
[TBL] [Abstract][Full Text] [Related]
4. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
[TBL] [Abstract][Full Text] [Related]
5. Implications of applicators orientations on bladder, and rectal doses in gynecological mHDR brachytherapy: A retrospective analysis of reproducibility in multi-fractionated regimen.
Srivastava AK; Rastogi M; Mishra SP
J Cancer Res Ther; 2019; 15(6):1345-1351. PubMed ID: 31898671
[TBL] [Abstract][Full Text] [Related]
6. Comparision of four different dose specification methods for high-dose-rate intracavitary radiation for treatment of cervical cancer.
Mai J; Erickson B; Rownd J; Gillin M
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1131-41. PubMed ID: 11704338
[TBL] [Abstract][Full Text] [Related]
7. Bladder-Rectum Spacer Balloon versus Vaginal Gauze Packing in High Dose Rate Brachytherapy in Cervical Cancer: A Randomised Study. Part II.
Rai B; Patel FD; Chakraborty S; Kapoor R; Sharma SC; Kumaravelu S; Raghukumar P; Aprem AS
Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):713-9. PubMed ID: 26144319
[TBL] [Abstract][Full Text] [Related]
8. Screens in ovoids of a Selectron cervix applicator.
Meertens H; van der Laarse R
Radiother Oncol; 1985 Jan; 3(1):69-80. PubMed ID: 3975442
[TBL] [Abstract][Full Text] [Related]
9. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
[TBL] [Abstract][Full Text] [Related]
10. A dosimetric comparison between applicators used for brachytherapy in carcinoma cervix - A single-institute prospective study.
Suryadevara A; Kumar MV; Vasundhara E; Alluri KR; Ahamed S; Guduru S
Indian J Cancer; 2018; 55(3):230-232. PubMed ID: 30693884
[TBL] [Abstract][Full Text] [Related]
11. A comparison between tandem and ovoids and interstitial gynecologic template brachytherapy dosimetry using a hypothetical computer model.
Hsu IC; Speight J; Hai J; Vigneault E; Phillips T; Pouliot J
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):538-43. PubMed ID: 11872302
[TBL] [Abstract][Full Text] [Related]
12. A comparison of organs at risk doses in GYN intracavitary brachytherapy for different tandem lengths and bladder volumes.
Siavashpour Z; Aghamiri MR; Jaberi R; ZareAkha N; Manshadi HRD; Kirisits C; Sedaghat M
J Appl Clin Med Phys; 2016 May; 17(3):5-13. PubMed ID: 27167253
[TBL] [Abstract][Full Text] [Related]
13. Quantification of intracavitary brachytherapy parameters and correlation with outcome in patients with carcinoma of the cervix.
Katz A; Eifel PJ
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1417-25. PubMed ID: 11121642
[TBL] [Abstract][Full Text] [Related]
14. Use of the rectal retractor to reduce the rectal dose in high dose rate intracavitary brachytherapy for a carcinoma of the uterine cervix.
Lee KC; Kim TH; Choi JH; Choi MS; Kim CY; Kim JY
Yonsei Med J; 2004 Feb; 45(1):113-22. PubMed ID: 15004877
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison of bladder, rectal, and vaginal surface doses between ovoids and cylinder-based vaginal brachytherapy in carcinoma of the endometrium.
Kumar NP; Kumar A; Jayaprakash PG; Raghukumar P; James FV
J Cancer Res Ther; 2018; 14(6):1191-1195. PubMed ID: 30488828
[TBL] [Abstract][Full Text] [Related]
16. [Optimization of dose distribution in combined irradiation of uterine cervix cancer with gamma-ray cesium-137 and X-9 MeV].
Lewocki M
Ann Acad Med Stetin; 1996; 42():199-222. PubMed ID: 9199121
[TBL] [Abstract][Full Text] [Related]
17. High dose rate (HDR) brachytherapy technique: for carcinoma of uterine cervix using Nucletron applicators.
Nair MT; Cheng MC; Barker A; Rouse BS
Med Dosim; 1995; 20(3):201-7. PubMed ID: 7576095
[TBL] [Abstract][Full Text] [Related]
18. Impact of brachytherapy applicators geometry on dose distribution in gynaecological cancer.
Rehman AU; Buzdar SA; Hassan M; Gadi A; Khan MA; Anjum MN
J Pak Med Assoc; 2016 Dec; 66(12):1566-1570. PubMed ID: 28179691
[TBL] [Abstract][Full Text] [Related]
19. Are doses to ICRU reference points valuable for predicting late rectal and bladder morbidity after definitive radiotherapy in uterine cervix cancer?
Kim HJ; Kim S; Ha SW; Wu HG
Tumori; 2008; 94(3):327-32. PubMed ID: 18705399
[TBL] [Abstract][Full Text] [Related]
20. Rectal and bladder dose reduction with the addition of intravaginal balloons to vaginal packing in intracavitary brachytherapy for cervical cancer.
Eng TY; Patel AJ; Ha CS
Brachytherapy; 2016; 15(3):312-318. PubMed ID: 27032995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
